Detalles de la búsqueda
1.
Impact of Hematopoietic Cell Transplantation on Myocardial Fibrosis in Young Patients with Sickle Cell Disease.
Blood
; 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38691679
2.
Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia.
Pediatr Nephrol
; 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38507119
3.
Microbiota Predict Infections and Acute Graft-Versus-Host Disease After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
J Infect Dis
; 228(5): 627-636, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37249910
4.
Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
Gene Ther
; 30(3-4): 222-231, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34997202
5.
Primary hypothyroidism in childhood cancer survivors: Prevalence, risk factors, and long-term consequences.
Cancer
; 128(3): 606-614, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34643950
6.
Hemophagocytic lymphohistiocytosis-like toxicity (carHLH) after CD19-specific CAR T-cell therapy.
Br J Haematol
; 194(4): 701-707, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34263927
7.
Hematopoietic cell transplant for reversal of liver fibrosis in a pediatric patient with erythropoietic protoporphyria.
Pediatr Transplant
; 25(6): e13966, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33405342
8.
Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia.
Biol Blood Marrow Transplant
; 25(2): 301-306, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30244103
9.
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access program.
Pediatr Blood Cancer
; 65(10): e27269, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873895
10.
Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.
Transpl Infect Dis
; 20(1)2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29178554
11.
Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2, and Haploidentical Natural Killer Cells.
Biol Blood Marrow Transplant
; 23(11): 1910-1917, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733263
12.
Defibrotide for Patients with Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome: Interim Results from a Treatment IND Study.
Biol Blood Marrow Transplant
; 23(6): 997-1004, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28285079
13.
Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
Cancer
; 123(19): 3791-3798, 2017 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28556917
14.
Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.
Br J Haematol
; 178(1): 112-118, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28444784
15.
Escalation to High-Dose Defibrotide in Patients with Hepatic Veno-Occlusive Disease.
Biol Blood Marrow Transplant
; 21(12): 2148-2153, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26278046
16.
Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability.
Pediatr Blood Cancer
; 62(4): 666-73, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25559618
17.
Natural killer cell therapy in children with relapsed leukemia.
Pediatr Blood Cancer
; 62(8): 1468-72, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25925135
18.
Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.
Biol Blood Marrow Transplant
; 20(8): 1224-8, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24769325
19.
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia.
Blood
; 120(2): 468-72, 2012 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22517895
20.
Longitudinal clinical data improve survival prediction after hematopoietic cell transplantation using machine learning.
Blood Adv
; 8(3): 686-698, 2024 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991991